These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33022228)

  • 1. Absence of Survival and Motor Deficits in 500 Repeat C9ORF72 BAC Mice.
    Mordes DA; Morrison BM; Ament XH; Cantrell C; Mok J; Eggan P; Xue C; Wang JY; Eggan K; Rothstein JD
    Neuron; 2020 Nov; 108(4):775-783.e4. PubMed ID: 33022228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and Motor Phenotypes in FVB C9-500 ALS/FTD BAC Transgenic Mice Reproduced by Multiple Labs.
    Nguyen L; Laboissonniere LA; Guo S; Pilotto F; Scheidegger O; Oestmann A; Hammond JW; Li H; Hyysalo A; Peltola R; Pattamatta A; Zu T; Voutilainen MH; Gelbard HA; Saxena S; Ranum LPW
    Neuron; 2020 Nov; 108(4):784-796.e3. PubMed ID: 33022226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD.
    Esanov R; Cabrera GT; Andrade NS; Gendron TF; Brown RH; Benatar M; Wahlestedt C; Mueller C; Zeier Z
    Mol Neurodegener; 2017 Jun; 12(1):46. PubMed ID: 28606110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
    Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH
    Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model.
    Nguyen L; Montrasio F; Pattamatta A; Tusi SK; Bardhi O; Meyer KD; Hayes L; Nakamura K; Banez-Coronel M; Coyne A; Guo S; Laboissonniere LA; Gu Y; Narayanan S; Smith B; Nitsch RM; Kankel MW; Rushe M; Rothstein J; Zu T; Grimm J; Ranum LPW
    Neuron; 2020 Feb; 105(4):645-662.e11. PubMed ID: 31831332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis.
    Lai JD; Ichida JK
    Neurosci Lett; 2019 Nov; 713():134523. PubMed ID: 31568865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C9ORF72-ALS/FTD: Transgenic Mice Make a Come-BAC.
    Hayes LR; Rothstein JD
    Neuron; 2016 May; 90(3):427-31. PubMed ID: 27151634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
    Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
    J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD.
    O'Rourke JG; Bogdanik L; Muhammad AKMG; Gendron TF; Kim KJ; Austin A; Cady J; Liu EY; Zarrow J; Grant S; Ho R; Bell S; Carmona S; Simpkinson M; Lall D; Wu K; Daughrity L; Dickson DW; Harms MB; Petrucelli L; Lee EB; Lutz CM; Baloh RH
    Neuron; 2015 Dec; 88(5):892-901. PubMed ID: 26637796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose hypometabolism prompts RAN translation and exacerbates C9orf72-related ALS/FTD phenotypes.
    Nelson AT; Cicardi ME; Markandaiah SS; Han JY; Philp NJ; Welebob E; Haeusler AR; Pasinelli P; Manfredi G; Kawamata H; Trotti D
    EMBO Rep; 2024 May; 25(5):2479-2510. PubMed ID: 38684907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD.
    Liu Y; Pattamatta A; Zu T; Reid T; Bardhi O; Borchelt DR; Yachnis AT; Ranum LP
    Neuron; 2016 May; 90(3):521-34. PubMed ID: 27112499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
    Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of the C9orf72 expansion in a Brazilian population.
    Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
    Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice.
    Pattamatta A; Nguyen L; Olafson HR; Scotti MM; Laboissonniere LA; Richardson J; Berglund JA; Zu T; Wang ET; Ranum LPW
    Hum Mol Genet; 2021 Feb; 29(24):3900-3918. PubMed ID: 33378537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.
    Moore S; Alsop E; Lorenzini I; Starr A; Rabichow BE; Mendez E; Levy JL; Burciu C; Reiman R; Chew J; Belzil VV; W Dickson D; Robertson J; Staats KA; Ichida JK; Petrucelli L; Van Keuren-Jensen K; Sattler R
    Acta Neuropathol; 2019 Jul; 138(1):49-65. PubMed ID: 30945056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
    Todd TW; Petrucelli L
    J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Role of DNA Damage in the Pathogenesis of the C9orf72 Repeat Expansion in Amyotrophic Lateral Sclerosis.
    Konopka A; Atkin JD
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.